Riskpilot← Back to searchSign inGet full accessRÅHOLT FYSIOTERAPI AS
ASActiveOrg 982281253Engerjordet 9, 2070 RåholtPhysiotherapy activities · NACE 8695Est. 20003 employees
Revenue 2025
NOK 3,3M
+32% vs 2024
EBITDA margin
2.2%
+95% vs 2024
Equity ratio
37.7%
Financial strength
Net profit 2025
NOK 47K
+143% vs 2024
| Revenue | NOK 3,3M | +32% |
| EBITDA | NOK 72K | +95% |
| Net profit | NOK 47K | +143% |
| Total assets | NOK 702K | +10% |
| Equity | NOK 265K | +21% |
| Employees | 3 | — |
Legal name
RÅHOLT FYSIOTERAPI AS
Org number
982281253
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
7. september 2000
Share capital
NOK 100 000
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Fysioterapi og andre relaterte virksomheter, samt utleie av lokaler til andre næringsdrivende.
Address
Engerjordet 9, 2070 Råholt
Phone
+4763951519
Email
lars@raaholtfysioterapi.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 926 | 3 063 | 3 253 | 2 482 | 3 278 |
| Staff expenses | −1 793 | −2 044 | −2 148 | −1 377 | −2 136 |
| EBITDA | 201 | 85 | 114 | 37 | 72 |
| Depreciation & amort. | −14 | −17 | −9 | −9 | −6 |
| EBIT | 188 | 68 | 106 | 28 | 66 |
| Net financials | 1 | 1 | 1 | 1 | 2 |
| Profit before tax | 189 | 69 | 107 | 29 | 68 |
| Tax | 48 | 16 | 25 | 10 | 21 |
| Net profit | 141 | 53 | 82 | 19 | 47 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 633 | 866 | 857 | 640 | 702 |
| Equity | 264 | 317 | 199 | 218 | 265 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 369 | 549 | 658 | 421 | 437 |
| Total debt | 369 | 549 | 658 | 421 | 437 |
EBITDA margin
2.2%
This company
15.8%
Market median
-86% vs market
20212025
Equity ratio
37.7%
This company
38.2%
Market median
+1% vs market
20212025
Return on equity
17.6%
This company
18.4%
Market median
+4% vs market
20212025
Net profit margin
1.4%
This company
8.1%
Market median
-83% vs market
20212025
Asset turnover
4.67×
This company
1.12×
Market median
+317% vs market
20212025
Debt / equity
1.65×
This company
0.62×
Market median
-166% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LA Chief Executive Officer | Chief Executive Officer | 2000 |
GM Deputy Member | Deputy Member | 2000 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2000 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of RÅHOLT FYSIOTERAPI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Anders Johnsen | Chief Executive Officer | 0 companies |
| Geir Misund | Deputy Member | 0 companies |
| Kirsten Misund | Chairman | 0 companies |